CONMED Corporation (CNMD)

Market Cap	2.12B
Revenue (ttm)	1.29B
Net Income (ttm)	131.74M
Shares Out	30.89M
EPS (ttm)	4.22
PE Ratio	16.26
Forward PE	14.76
Dividend	$0.80 (1.17%)
Ex-Dividend Date	Sep 16, 2024

Volume	367,721
Open	69.30
Previous Close	69.80
Day's Range	68.15 - 71.49
52-Week Range	61.05 - 114.80
Beta	1.47
Analysts	Buy
Price Target	82.83 (+20.69%)
Earnings Date	Jan 29, 2025

About CNMD

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 23, 1987
• Employees: 4,000
• Stock Exchange: NYSE
• Ticker Symbol: CNMD
• Website: https://www.conmed.com

Analyst Forecast

According to 6 analysts, the average rating for CNMD stock is "Buy." The 12-month stock price forecast is $82.83, which is an increase of 20.69% from the latest price.

Price Target

$82.83

(20.69% upside)

Analyst Consensus: Buy